Buprenorphine
42 brands · 35 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 7%
Price room
max/min price ratio 17.04x across 10 trusted points (Rs 66.44-1131.86). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 8 live products for Buprenorphine — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(22) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.
Market saturation
35 canonical companies and 42 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 17.04x across 10 trusted points (Rs 66.44-1131.86). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2024-05-29 incl. recall/safety.
Confidence
Full coverage.
Packaged brief for this strong opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules